Loading...

SOHO 2026 Annual Meeting

This website and third-party tools we use rely on cookies for the best user experience. By selecting "I agree", you agree to cookie usage as described in our Privacy Policy.

1,267 posters, 47 videos, 13 topics, 4 sessions, 853 authors

ePostersLive by SciGen Technologies S.A. All rights reserved.

SOHO 2026 Annual Meeting

September 9 - 12, 2026 | George R. Brown Convention Center, Houston, Texas

Home Posters by Code Posters by Title Authors Topics Sessions Videos Previous meetings

Posters by Session

Select Session

Thumbnail for Slowing Mortality Gains in Multiple Myeloma Despite Novel Therapies: Global and SDI-Based Disparities From the GBD 2023 Study (1990-2023)

MM - 207

Slowing Mortality Gains in Multiple Myeloma Despite Novel Therapies: Global and SDI-Based Disparities From the GBD 2023 Study (1990-2023)

Tapan Giri

Poster Presenter: Tapan Giri

Thumbnail for Phase 3 Randomized Trial of Anselamimab Demonstrates Improvement in All-Cause Mortality in ? Light-Chain Amyloidosis

MM - 218

Phase 3 Randomized Trial of Anselamimab Demonstrates Improvement in All-Cause Mortality in ? Light-Chain Amyloidosis

Giada Bianchi

Poster Presenter: Giada Bianchi

Thumbnail for Understanding the Symptom Burden and Health-Related Quality of Life Among Black Patients With Multiple Myeloma: A Retrospective Analysis of Patient-Reported Data

Previous 1...112 113 114 115 116 117 118...141 Next

Copyright © 2015-2026, ePostersLive® SciGen is a registered trademark of SciGen Technologies S.A. Patent pending.

MM - 220

Understanding the Symptom Burden and Health-Related Quality of Life Among Black Patients With Multiple Myeloma: A Retrospective Analysis of Patient-Reported Data

Osborn Owusu Ansah

Poster Presenter: Osborn Owusu Ansah

$Thumbnail for Outcomes and Toxicity of CAR T-Cell Therapy in Patients With Renal Impairment: A Propensity Score-Matched Analysis in Relapsed/Refractory Multiple Myeloma$

MM - 224

Outcomes and Toxicity of CAR T-Cell Therapy in Patients With Renal Impairment: A Propensity Score-Matched Analysis in Relapsed/Refractory Multiple Myeloma

Anushareddy Muddasani

Poster Presenter: Anushareddy Muddasani

Thumbnail for Early Real-World Utilisation, Resource Use, and In-Hospital Outcomes of BCMA-Directed Bispecific Antibodies in Multiple Myeloma: A National Inpatient Analysis, 2022-2023

MM - 225

Early Real-World Utilisation, Resource Use, and In-Hospital Outcomes of BCMA-Directed Bispecific Antibodies in Multiple Myeloma: A National Inpatient Analysis, 2022-2023

Aniqa Baloch

Poster Presenter: Aniqa Baloch

$Thumbnail for Safety and Effectiveness of Bispecific Antibody Therapy Across the Spectrum of Kidney Function in Relapsed/Refractory Multiple Myeloma$

MM - 226

Safety and Effectiveness of Bispecific Antibody Therapy Across the Spectrum of Kidney Function in Relapsed/Refractory Multiple Myeloma

Anushareddy Muddasani

Poster Presenter: Anushareddy Muddasani

Thumbnail for Distinct Inpatient and Post-Discharge Risk States Defined by AKI and Acute Dialysis in Multiple Myeloma Hospitalizations

MM - 251

Distinct Inpatient and Post-Discharge Risk States Defined by AKI and Acute Dialysis in Multiple Myeloma Hospitalizations

Woo Joo Lee

Poster Presenter: Woo Joo Lee

$Thumbnail for Reduced-Frequency Dosing of FDA-Approved Bispecific Antibodies in Relapsed/Refractory Multiple Myeloma: A Systematic Review of Maintaining Efficacy While Reducing Infection-Related Toxicity$

MM - 263

Reduced-Frequency Dosing of FDA-Approved Bispecific Antibodies in Relapsed/Refractory Multiple Myeloma: A Systematic Review of Maintaining Efficacy While Reducing Infection-Related Toxicity

Mahboob Younus Shaik

Poster Presenter: Mahboob Younus Shaik

Thumbnail for Cardiovascular Adverse Events Associated With Immune Checkpoint Inhibitors in Hematologic Malignancies: A Systematic Review of Recent Clinical Studies

MM - 265

Cardiovascular Adverse Events Associated With Immune Checkpoint Inhibitors in Hematologic Malignancies: A Systematic Review of Recent Clinical Studies

Yusuf Shahab

Poster Presenter: Yusuf Shahab

ePosters in

Topics Sessions

Acute Lymphoblastic Leukemia (ALL)(71)Acute Myeloid Leukemia (AML)(230)Aggressive B-Cell Lymphoma (ABCL)(114)Cellular Therapy (CT)(128)Chronic Lymphocytic Leukemia (CLL)(110)Chronic Myeloid Leukemia (CML)(55)Hodgkin Lymphoma (HL)(54)Indolent B-Cell Lymphoma (IBCL)(47)Mantle Cell Lymphoma (MCL)(23)Multiple Myeloma (MM)(234)

Previous 1 2 Next

Sponsors